Abstract
Ovarian hyperstimulation syndrome (OHSS) is the most serious iatrogenic complication associated with ovarian stimulation. It is only in recent years that the understanding of OHSS has advanced sufficiently to develop treatment options aimed at reducing the incidence and effects of OHSS. Currently, there is no good test or method for identifying susceptible patients. Nevertheless, progress has been made in the prevention of OHSS. Physicians have a wide range of treatment options, including coasting, re-initiation of a GnRH antagonist, and application of agonists, like dopamine in the luteal phase or triggering oocyte maturation with a bolus of GnRH agonist. These treatments, together with other procedures, like oocyte/embryo vitrification, have allowed physicians to improve the prediction and prevention of OHSS.
Keywords: Agonist triggering, ART, hCG, OHSS, prevention.
Current Drug Targets
Title:GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence
Volume: 14 Issue: 8
Author(s): Maria Cerrillo Martinez, Francisco J. Ruiz and Juan A. García-Velasco
Affiliation:
Keywords: Agonist triggering, ART, hCG, OHSS, prevention.
Abstract: Ovarian hyperstimulation syndrome (OHSS) is the most serious iatrogenic complication associated with ovarian stimulation. It is only in recent years that the understanding of OHSS has advanced sufficiently to develop treatment options aimed at reducing the incidence and effects of OHSS. Currently, there is no good test or method for identifying susceptible patients. Nevertheless, progress has been made in the prevention of OHSS. Physicians have a wide range of treatment options, including coasting, re-initiation of a GnRH antagonist, and application of agonists, like dopamine in the luteal phase or triggering oocyte maturation with a bolus of GnRH agonist. These treatments, together with other procedures, like oocyte/embryo vitrification, have allowed physicians to improve the prediction and prevention of OHSS.
Export Options
About this article
Cite this article as:
Martinez Cerrillo Maria, Ruiz J. Francisco and García-Velasco A. Juan, GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence, Current Drug Targets 2013; 14 (8) . https://dx.doi.org/10.2174/13894501113149990163
DOI https://dx.doi.org/10.2174/13894501113149990163 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiotoxicity of Tyrosine-Kinase-Targeting Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature
Current Medical Imaging The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis
Current Radiopharmaceuticals Stroke and COVID-19 Pandemic: The Dilemma
Coronaviruses Myocardial Inflammation in Autoimmune Diseases: Investigation by Cardiovascular Magnetic Resonance and Endomyocardial Biopsy
Inflammation & Allergy - Drug Targets (Discontinued) Pathophysiology of Post-Operative Low Cardiac Output Syndrome
Current Vascular Pharmacology Infective Endocarditis Complicating Hypertrophic Obstructive Cardiomyopathy: Is Antibiotic Prophylaxis Really Unnecessary?
Current Cardiology Reviews The Use of Echocardiography in the Critically Ill; The Role of FADE (Fast Assessment Diagnostic Echocardiography) Training
Current Cardiology Reviews Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Sirolimus: A Novel Immunosuppressive Drug in Heart Transplantation
Recent Patents on Cardiovascular Drug Discovery Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature
Current Cardiology Reviews The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices
Current Pharmaceutical Design Cardio-Vascular Risks Associated with Clozapine Treatment
Current Psychiatry Reviews Antiangiogenic Therapy and Ovarian Cancer
Current Women`s Health Reviews Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
Cardiovascular & Hematological Disorders-Drug Targets Can Chest Computed Tomography Findings of Symptomatic COVID-19 Patients Upon Admission Indicate Disease Prognosis and Clinical Outcome?
Current Medical Imaging Phytoconstituents of <i>Lantana camara</i> L.: Rekindling Hope in the Cancer Treatment
Current Bioactive Compounds Heart Failure in Chronic Myocarditis: A Role for microRNAs?
Current Genomics Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in Experimental Myocarditis
Current Pharmaceutical Design Pulmonary Arterial Hypertension in Connective Tissue Diseases
Current Respiratory Medicine Reviews